| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 8442770 | European Journal of Cancer | 2014 | 9 Pages |
Abstract
The combination of bevacizumab and capecitabine showed clinical activity and a manageable safety profile in the treatment of GI-NETs that warrant confirmation in a randomised phase III trial.
Keywords
Related Topics
Life Sciences
Biochemistry, Genetics and Molecular Biology
Cancer Research
Authors
Emmanuel Mitry, Thomas Walter, Eric Baudin, Jean-Emmanuel Kurtz, Philippe Ruszniewski, Sophie Dominguez-Tinajero, Leïla Bengrine-Lefevre, Guillaume Cadiot, Clarisse Dromain, Françoise Farace, Philippe Rougier, Michel Ducreux,